Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Postoperative Bleeding in Sinus and Nasal Surgery
NCT04754230Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jun 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in Postoperative bleeding (2 arms), sponsored by Stanford University. Primary endpoints: Bleeding Visual Analog Scale at 7 days and Gauze Saturation Visual Analog Scale at 7 days. Started Jun 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Postoperative bleeding
Beyond the preview
Go deeper on NCT04754230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754230.